ArticleBMC global and public health2026
Women engaged in commercial sex living with Human Immunodeficiency Virus and viral non-suppression in Uganda: analysis of multiple respondent-driven sampling surveys, 2021-2023.
Article in BMC global and public health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Erratum issued
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundHuman Immunodeficiency Virus (HIV) Viral load non-suppression (VNS) among women engaged in commercial sex (WECS) is unknown even with persistent new HIV infections in the general population. The objective of this study was to find out the factors correlated with VNS among WECS living with HIV (WECS-LHIV) in Uganda.
methodsCross-sectional data were collected through respondent driven sampling (RDS) in Kampala Capital City and 11 upcountry towns. All consented WECS-LHIV reporting commercial sex 3 months prior to the surveys were tested for HIV and viral load (VL), active syphilis and high-risk human papilloma virus (hr.HPV) which was based on genotypes 16 and 18 that are highly associated with all cervical cancer cases. VNS was defined as any VL measure < 1,000 copies/ml. Analysis of correlates of VNS were restricted to WECS-LHIV with VL results irrespective of their antiretroviral therapy (ART) status. We examined variables including - age, marital status, education, active syphilis, hr.HPV and reported ART use to identify correlates of VNS. Sampling weights to reflect the complex sampling design were applied.
resultsOf 2,674 WECS-LHIV (median age 32 years, interquartile range (IQR) 27-37), 667 (24.9%) had VNS. The findings show that 19.2% and 29.7% of WECS-LHIV with VNS had active syphilis and hr.HPV co-infections respectively. WECS-LHIV had reduced odds of VNS if they were aged 30-49 years ([adjusted odds ratio (aOR): 0.46, 95% confidence interval (CI): 0.30-0.69, p < 0.001)] vs. 18-24 years and if they self-reported ART use [aOR: 0.38, 95% CI: 0.28-0.52, p = < 0.001 vs. non-self-reporting ART].
conclusionsYoung women engaged in commercial sex(YWECS) and none ART disclosure WECS may increase risk of new HIV infections in general population. Increase on frequency of ART adherence and viral load monitoring of YWECS including continuous surveillance of the second and third 95 HIV continuum of care and treatment for hidden populations may aid in reduction of new HIV infections burden in Uganda and other low- and middle-income countries.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.